- Home
- CTSO vs PLBY Comparison
CTSO vs PLBY Comparison
Compare CTSO & PLBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- PLBY
- Stock Information
- Founded
- CTSO 1997
- PLBY 1953
- Country
- CTSO United States
- PLBY United States
- Employees
- CTSO N/A
- PLBY N/A
- Industry
- CTSO Medical/Dental Instruments
- PLBY Recreational Games/Products/Toys
- Sector
- CTSO Health Care
- PLBY Consumer Discretionary
- Exchange
- CTSO Nasdaq
- PLBY Nasdaq
- Market Cap
- CTSO 57.2M
- PLBY 53.2M
- IPO Year
- CTSO N/A
- PLBY N/A
- Fundamental
- Price
- CTSO $0.98
- PLBY $1.11
- Analyst Decision
- CTSO Strong Buy
- PLBY Buy
- Analyst Count
- CTSO 3
- PLBY 2
- Target Price
- CTSO $4.67
- PLBY $2.35
- AVG Volume (30 Days)
- CTSO 147.2K
- PLBY 8.4M
- Earning Date
- CTSO 11-07-2024
- PLBY 11-12-2024
- Dividend Yield
- CTSO N/A
- PLBY N/A
- EPS Growth
- CTSO N/A
- PLBY N/A
- EPS
- CTSO N/A
- PLBY N/A
- Revenue
- CTSO $37,739,531.00
- PLBY $72,188,000.00
- Revenue This Year
- CTSO $13.09
- PLBY N/A
- Revenue Next Year
- CTSO $15.68
- PLBY N/A
- P/E Ratio
- CTSO N/A
- PLBY N/A
- Revenue Growth
- CTSO 1.80
- PLBY N/A
- 52 Week Low
- CTSO $0.70
- PLBY $0.44
- 52 Week High
- CTSO $2.15
- PLBY $1.55
- Technical
- Relative Strength Index (RSI)
- CTSO 44.01
- PLBY 54.66
- Support Level
- CTSO $0.71
- PLBY $0.85
- Resistance Level
- CTSO $0.99
- PLBY $1.14
- Average True Range (ATR)
- CTSO 0.09
- PLBY 0.18
- MACD
- CTSO 0.00
- PLBY -0.01
- Stochastic Oscillator
- CTSO 59.97
- PLBY 38.24
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales, Distributors/strategic partners, and Government segments. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About PLBY PLBY Group Inc.
PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.